Carl Michael Gay

12PUBLICATIONS
120CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 27, 2026
Neoadjuvant durvalumab plus chemotherapy in resectable or borderline resectable non-small-cell lung cancer: the phase 2 MDT-BRIDGE trial.

|Apr 23, 2026
Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity.

|Apr 03, 2026
Treatment monitoring by biomarker analysis in a Phase I dose-expansion study of AZD2811 for relapsed/refractory small-cell lung cancer.

Melissa L Johnson, Giulia Fabbri, Carmela Ciardullo

|Dec 18, 2025
Small Cell Lung Cancer Classification: Unraveling Heterogeneity to Enable Personalized Treatments.

Kristiina Boettiger, Ildikó Kovács, Lilla Horvath

|Jun 24, 2025
Multidimensional Analysis of B7 Homolog 3 RNA Expression in Small Cell Lung Cancer Molecular Subtypes.

Carl M Gay, Taofeek K Owonikoko, Lauren A Byers

|Jun 05, 2025
The current and emerging immunotherapy paradigm in small-cell lung cancer.

Kang Qin, Carl M Gay, Lauren A Byers

Pageof 2

Frequent Collaborators

10 joint publications

Lauren Averett Byers

6 joint publications

Jianjun Zhang

5 joint publications

John Victor Heymach

5 joint publications

Don L Gibbons